Surrozen (SRZN) Earnings Date & Reports

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SRZN is expected to report earnings to rise 158.54% to -105 cents per share on November 11

Q3'26

Est.

$-1.06

Q2'26

Beat

by $0.88

Q1'26

Missed

by $10.66

Q4'25

Missed

by $18.10

Q2'25

Beat

by $3.16

The last earnings report on August 06 showed earnings per share of -40 cents, beating the estimate of -128 cents. With 67.26K shares outstanding, the current market capitalization sits at 281.97M.

View a ticker or compare two or three

SRZN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days